ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 957,57
0,54%
Dow Jones
38 675,68
1,18%
DAX
18 001,60
0,54%
Brent Oil
82,765
0,00%
Bitcoin
63 137,60
0,39%
Registration Strip Icon for discussion Inscrivez-vous pour interagir sur nos forums actifs pour discuter avec des investisseurs aux idées similaires.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. CorMedix Inc (CRMD)

  7. CorMedix Inc (CRMD) Actualités

CRMD CorMedix Inc

5,83
0,46 (8,57%)
04 Mai 2024 - Fermé
Retardé de 15 minutes
Nom Action Symbole Action Marché Type
CorMedix Inc CRMD NASDAQ Action ordinaire
  Variation Action Variation Action% Cours Dernier Dernier échange
Upgrade Icon
0,46 8,57% 5,83 02:00:00
Ouverture Plus Bas Plus Haut Prix de clôture Clôture Veille
5,49 5,4305 5,92 5,84 5,37
plus d'informations sur les cotations »

Actualités Recentes

Date Heure Source Titre
19/4/202414:30GLOBECorMedix Inc. Announces CMS Grants TDAPA to DefenCath
15/4/202414:30GLOBECorMedix Inc. Announces U.S. Inpatient Commercial..
12/3/202412:30GLOBECorMedix Inc. Reports Fourth Quarter and Full Year 2023..
30/1/202423:26EDGAR2Form 8-K - Current report
18/1/202422:53EDGAR2Form 4/A - Statement of changes in beneficial ownership of..
18/1/202402:11EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18/1/202402:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18/1/202402:09EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18/1/202402:04EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/12/202314:39EDGAR2Form 8-K - Current report
14/12/202322:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21/11/202322:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/11/202322:11EDGAR2Form 8-K - Current report
14/11/202322:05GLOBECorMedix Inc. Reports Third Quarter and Nine Month 2023..
30/10/202321:35EDGAR2Form 8-K - Current report
11/10/202314:30GLOBECorMedix Inc. Announces Abstract Presentation at Upcoming..
13/9/202323:25EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
13/9/202323:20EDGAR2Form DEF 14A - Other definitive proxy statements
08/9/202322:21EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/9/202314:30GLOBECorMedix Inc. Announces Publication of Phase 3 LOCK IT-100..
30/8/202314:00GLOBECorMedix Inc. Announces Issuance of U.S. Patent Covering..
17/8/202314:30EDGAR2Form 8-K - Current report
08/8/202314:12EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
08/8/202313:45EDGAR2Form 8-K - Current report
08/8/202313:30GLOBECorMedix Inc. Reports Second Quarter and Six Month 2023..
30/6/202322:40EDGAR2Form 8-K - Current report
30/6/202322:38EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
29/6/202304:57GLOBECorMedix Inc. Announces Pricing of $40 Million Public..
28/6/202323:13EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
28/6/202322:07GLOBECorMedix Inc. Announces Proposed Public Offering of Common..
21/6/202314:30GLOBECorMedix Inc. Announces FDA Acceptance of Resubmission of..
15/6/202314:30GLOBECormedix Inc. Announces Strategic Initiative With Boston..
16/5/202313:00GLOBECorMedix Inc. Announces Resubmission of New Drug Application..
15/5/202322:05GLOBECorMedix Inc. Reports First Quarter 2023 Financial Results..

Dernières Valeurs Consultées

NASDAQ
CRMD
CorMedix
Delayed Upgrade Clock
ADVFN Logo

France
Société
Entreprise
Popular
Obtenir l'application

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés